CAR T-cell therapy – Redefining blood cancer treatment
CAR T-cell therapy is a novel type of immunotherapy. It is designed to strengthen and harness the immune systems inherent cancer eliminating powers by genetically modifying our T-cells, a vital part of our immune system.
Find out more at : http://bit.ly/2Y8ejoo
CAR T-cell therapy is a type of adoptive cell therapy, custom made for each patient using their own T-cells. Our T-cells play a vital role in our immune system, orchestrating the immune response in our bodies by killing cells that have become infected by pathogens (bacteria or germs capable of causing disease).
On the surface of every cancer cell, there are specific antigens relating to that type of cancer. These are foreign toxins that normally induce an immune response within our body. However, sometimes our T-cell lymphocytes that search for infections stop recognising antigens as foreign and no longer destroy them, which is how cancer develops. In CAR T-cell therapy, these genetically modified T-cells are designed to recognise and eradicate specific antigens on tumour cells.
CAR T-cell therapy is the latest breakthrough in immunotherapy treatment and can be used to treat some blood cancers that have not responded to conventional chemotherapy.
At HCA Healthcare UK, we are committed to providing the very best care and access to emerging therapies as soon as they are available. We will be one of the first JACIE-IECT accredited private providers in the UK to offer the latest CAR T-cell therapy.
No comments found